2Sankar C, Mundkur N.Cerebral Palsy-definition, Classification, Etiology and Early Diagnosis[ J ].India J Pediatr,2005,72(10):865- 868.
3Mochizuki N, Moriyama Y, Takagi N, et al. Intravenous injection of neural progenitor cells improves cerebral ischemia-induced learning dysfunction [J]. Biol Pharm Bull,2011, 34(2): 260-265.
3Kim H J, Choi Y, Min W S, et al. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia [J]. Transplantation ,2007 ( 4 ) : 1082-1091.
4Nishida T, Akatsuka Y, Morishima Y, et al. Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2AI, ACC-I , in patients receiving HLA genotypically matched unrelated bone marrow transplant [J]. Br J Haematol, 2004,124 ( 5 ) : 629 -635.
5Giorgini A, Noble A. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4 ^+ CD25 ^+ Foxp3 ^+ regulatory T cells in nonlymphopenic hosts [J]. J Leukoc Biol, 2007,82 ( 5 ) : 1053-1061.
6Jung U, Foley J E, Erdmann A A, et al. Ex vivo rapamycin generates Thl/Tcl or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to posttransplant rapamycin therapy [ J ]. Biol Blood Marrow Trans- plant, 2006,12 ( 9 ) : 905-918.
7Simpson D. New developments in the prophylaxis and treatment of graft versus host disease[ J ]. Expert Opin Pharmacother,2001,2(7) :1109-1117.
8Creamer D, Martyn-Simmons C L, Osborne G,et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy [J]. Arch Dermato1,2007,143 ( 9 ) : 1157-1162.
9Endimiani A,Paterson D L. Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases[J]. Semin Respir Crit Care Med, 2007,28 (6) :646-655.
10Jones R N, Sader H S, Fritsche T R,et al. Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem [J]. Diagn Microbiol Infect Dis, 2007,59 ( 4 ) : 467 -472.
